Cassava enters into a license agreement with Yale University granting intellectual property rights, including rights to an ...

The licensing deal follows years of controversy for Cassava, as well as the high-profile late-stage failure of its ...

Cassava Sciences SAVA, a clinical-stage biotech focusing on developing novel products to detect and treat neurodegenerative ...

Outer Richmond in 2012, first making a name for itself with its Japanese breakfast before moving to North Beach and pivoting ...

H.C. Wainwright analyst Vernon Bernardino reiterated a Hold rating on Cassava Sciences (SAVA – Research Report) today. The company’s shares ...

The Federal Government has pledged its support for Agbeyewa Farms investment in cassava farming and agro-processing, ...

It appears there is some serious shaking up going on in the Econet Group. Just this past weekend, we were talking about the ...

Shares of Cassava Sciences, Inc. (NASDAQ: SAVA) climbed 7% following the company's announcement of securing an exclusive license to a method of treatment patent f ...

Explore Cassava Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SAVA. Benzinga Bulls And Bears: Amazon, Tesla, Rivian, Palantir And How Dogecoin ...

Cassava Sciences SAVA, a clinical-stage biotech focusing on developing novel products to detect and treat neurodegenerative diseases, such as Alzheimer’s disease (AD), is expected to report ...